Dr. Reddy's Recalls Tizanidine Tablets Due to Illegible Labeling
Dr. Reddy's Laboratories is recalling Tizanidine Tablets because bottle labels may be missing the product strength and other printing details.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The hazard is limited to packaging/labeling issues.
Plain-English summary
Dr. Reddy's Laboratories is voluntarily recalling Tizanidine Tablets USP, 4 mg, 150-count bottles. The recall is due to a labeling defect where the bottle labels may not contain the product strength or other printing details, making them illegible.
The affected product is Tizanidine Tablets USP, 4 mg, manufactured by Dr. Reddy's Laboratories Limited in India. The specific lot numbers involved are C208625, C208984, C209113, C209369 (Exp 09/15), and C209680 (Exp 10/15). The NDC number is 55111-180-15. A total of 117,546 bottles were distributed nationwide and in Puerto Rico.
Consumers should check their medication bottles for these specific lot numbers and expiration dates. If the label is illegible or missing the strength information, they should contact their pharmacist or Dr. Reddy's Laboratories for a replacement or refund. This recall is classified as Class III by the FDA, indicating a remote probability of adverse health consequences.
The recalled product
- Product
- TIZANIDINE (TIZANIDINE)
- Brand
- TIZANIDINE
- Manufacturer
- Dr. Reddy'S Laboratories
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 117,546
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: C208625
- C208984
- C209113
- C209369
- Exp 09/15
- and C209680
- Exp 10/15.
UPCs (2)
- 0355111180104
- 0355111179108
Distribution
Related recalls
Same brand · TIZANIDINE
- HighTizanidine 4mg Tablets Recalled for Contamination with 2mg Tablets
FDA (Drugs) · 2024-01-17
- HighTizanidine Tablets Recalled Nationwide for Failed Dissolution Specification
FDA (Drugs) · 2023-07-26
- ModeratePrescription Drug Tizanidine Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2023-07-12
- ModerateTizanidine tablets recalled nationwide for failed stability specifications
FDA (Drugs) · 2023-07-12
- ModerateTizanidine Tablets Recalled for Failed Specifications Due to Shaved Tablets
FDA (Drugs) · 2021-08-25
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02